Open AccessSuccessful rechallenge with cetuximab after progression with nivolumab for recurrent cervical lymph node metastasis from carcinoma of the tongue
Author(s) -
Asada Yasuyuki,
Teramura Chitoshi,
Wada Takuma,
Machida Yoshisato,
Koshinuma Shinya,
Yamamoto Gaku
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4464
Subject(s) - medicine , cetuximab , nivolumab , oncology , metastasis , lymph node metastasis , nasopharyngeal carcinoma , lymph node , cervical lymph nodes , immunotherapy , cancer , radiation therapy , colorectal cancer
Abstract We can infer that the immunostimulatory effect of nivolumab and reactivation of cetuximab enhance the antitumor effect of the therapy.